Gastroesophageal reflux disease (GERD) continues to be among the most common
diseases seen by gastroenterologists, surgeons, and primary care physicians. Our …

Background & Aims As many as one-half of all patients with suspected gastroesophageal
reflux disease (GERD) do not derive benefit from acid suppression. This review outlines a …

Clinical history, questionnaire data and response to antisecretory therapy are insufficient to
make a conclusive diagnosis of GERD in isolation, but are of value in determining need for …

Gastroesophageal reflux disease (GERD) is a condition in which gastric contents regurgitate
into the esophagus or beyond, resulting in either troublesome symptoms or complications …

Management of gastroesophageal reflux disease (GERD) commonly starts with an empiric
trial of proton pump inhibitor (PPI) therapy and complementary lifestyle measures, for …

Up to 40% of patients with symptoms suspicious of gastroesophageal reflux disease (GERD)
do not respond completely to proton pump inhibitor (PPI) therapy. The term “refractory …

Аннотация Цель. Настоящие рекомендации Российской гастроэнтерологической
ассоциации разработаны с целью ознакомления практикующих врачей с …

Introduction: The introduction of proton pump inhibitors (PPIs) into clinical practice has
greatly improved our therapeutic approach to acid-related diseases for their efficacy and …

Background High‐resolution manometry (HRM) has resulted in new revelations regarding
the pathophysiology of gastro‐esophageal reflux disease (GERD). The impact of new HRM …

Recommendations of the Russian Gastroenterological Association in Diagnosis and
Treatment of Gastroesophageal Reflux Disease | Ivashkin | Russian Journal of …